E2F-1 Potentiates cell death by blocking antiapoptotic signaling pathways

Molecular Cell

Volumn 4, Issue 5, 1999, Pages 771-781

  Phillips, Andrew C ^a   Ernst, Mary K ^a   Bates, Stewart ^b   Rice, Nancy R ^a   Vousden, Karen H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; PROTEIN P53; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR E2F; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; DNA BINDING; DNA SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; INHIBITION KINETICS; PROTEIN EXPRESSION; SENSITIZATION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; TUMOR CELL LINE;

EID: 0033231615     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80387-1     Document Type: Article

References (59)

1. Adams, J.M., and Cory, S. (1998). The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322-1326.
2. Ashkenazi, A., and Dixit, V.M. (1998). Death receptors: signaling and modulation. Science 281, 1305-1308.
3. Basu, S., and Kolesnick, R. (1998). Stress signals for apoptosis: ceramide and c-Jun kinase. Oncogene 17, 3277-3285.
4. Bates, S., and Vousden, K.H. (1999). Mechanisms of p53-mediated apoptosis. Cell. Mol. Life Sci. 55, 28-37.
5. ARF links the tumour suppressors RB and p53. Nature 395, 124-125.
6. Beg, A.A., and Baltimore, D. (1996). An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274, 782-784.
7. Bradham, C.A., Qian, T., Streetz, K., Trautwein, C., Brenner, D.A., and Lemasters, J.J. (1998). The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol. Cell. Biol. 18, 6353-6364.
8. Brownell, E., Mittereder, N., and Rice, N.R. (1989). A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon. Oncogene 4, 935-942.
9. Bump, N.J., Hackett, M., Hugunin, M., Seshagiri, S., Brady, K., Chen, P., Ferenz, C., Franklin, S., Ghayur, T., Li, P., and et al. (1995). Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 269, 1885-1888.
10. Chinnaiyan, A.M., O'Rourke, K., Yu, G.L., Lyons, R.H., Garg, M., Duan, D.R., Xing, L., Gentz, R., Ni, J., and Dixit, V.M. (1996). Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274, 990-992.
11. Degli-Esposti, M.A., Dougall, W.C., Smolak, P.J., Waugh, J.Y., Smith, C.A., and Goodwin, R.G. (1997). The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity 7, 813-820.
12. DeGregori, J., Leone, G., Miron, A., Jakoi, L., and Nevins, J.R. (1997). Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94, 7245-7250.
13. Duckett, C.S., and Thompson, C.B. (1997). CD-30-depdendent degradation of TRAF-2: implicatyions for negative regulation of TRAF signaling and the control of cell survival. Genes Dev. 11, 2810-2821.
14. Dyson, N. (1998). The regulation of E2F by pRB-family proteins. Genes Dev. 12, 2245-2262.
15. Garcia-Calvo, M., Peterson, E.P., Leiting, B., Ruel, R., Nicholson, D.W., and Thornberry, N.A. (1998). Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. 273, 32608-32613.
16. Green, D.R., and Reed, J.C. (1998). Mitochondria and apoptosis. Science 281, 1309-1312.
17. Hall, M., and Peters, G. (1996). Genetic alteraions of cyclins, cyclin dpendent kinases and cdk inhibitors in human cancers. Adv. Cancer Res. 68, 67-108.
18. Helin, K., Wu, C., Fattaey, A., Lees, J., Dynlacht, B., Ngwu, C., and Harlow, E. (1993). Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative transactivation. Genes Dev. 7, 1850-1861.
19. Hsieh, J.-K., Fredersdorf, S., Kouzarides, T., Martin, K., and Lu, X. (1997). E2F-1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev. 11, 1840-1852.
20. Hsu, H., Xiong, J., and Goeddel, D.V. (1995). The TNF receptor 1-associated protein TRADD signals cell death and NF-activation. Cell 81, 495-504.
21. Hsu, H., Shu, H.B., Pan, M.G., and Goeddel, D.V. (1996). TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299-308.
22. L interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc. Natl. Acad. Sci. USA 95, 4386-4391.
23. Hueber, A.-O., Zörnig, M., Lyon, D., Suda, T., Nagata, S., and Evan, G.I. (1997). requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science 278, 1305-1309.
24. Inohara, N., Koseki, T., Hu, Y., Chen, S., and Núñez, G. (1997). CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis. Proc. Natl. Acad. Sci. USA 94, 10717-10722.
25. Kieran, M., Blank, V., Logeat, F., Vandekerchove, J., Lottspeich, F., Le Bail, O., Urban, M.B., Kourilsky, P., Baeuerle, P.A., and Israel, A. (1990). The DNA binding subunit of NF-κ is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62, 1007-1018.
26. Klefstrom, J., Arighi, E., Littlewood, T., Jäättela, M., Saksela, E., Evan, G.I., and Alitalo, K. (1997). Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-κB activation. EMBO J. 16, 7382-7392.
27. Kubbutat, M.H., Ludwig, R.L., Levine, A.J., and Vousden, K.H. (1999). Analysis of the degradation function of Mdm2. Cell Growth Differ. 10, 87-92.
28. Kuwana, T., Smith, J.J., Muzio, M., Dixit, V., Newmeyer, D.D., and Kornbluth, S. (1998). Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. J. Biol. Chem. 273, 16589-16594.
29. Lee, S.Y., Reichlin, A., Santana, A., Sokol, K.A., Nussenzweig, M.C., and Choi, Y. (1997). TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival. Immunity 7, 703-713.
30. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, E.S., and Wang, X. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489.
31. Liu, Z.G., Hsu, H., Goeddel, D.V., and Karin, M. (1996). Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87, 565-576.
32. Macleod, K.F., Hu, Y., and Jacks, T. (1996). Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J. 15, 6178-6188.
33. Marsters, S.A., Sheridan, J.P., Pitti, R.M., Huang, A., Skubatch, M., Baldwin, D., Yuan, J., Gurney, A., Goddard, A.D., Godowski, P., and Ashkenazi, A. (1997). A novel receptor for Apo2L/TRAIL contains a truncated death domain. Curr. Biol. 7, 1003-1006.
34. Marsters, S.A., Sheridan, J.P., Pitti, R.M., Brush, J., Goddard, A., and Ashkenazi, A. (1998). Identification of a ligand for the death-domain-containing receptor Apo3. Curr. Biol. 8, 525-528.
35. Muzio, M., Stockwell, B.R., Stennicke, H.R., Salvesen, G.S., and Dixit, V.M. (1998). An induced proximity model for caspase-8 activation. J. Biol. Chem. 273, 2926-2930.
36. Nevins, J.R. (1998). Towards an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9, 585-593.
37. Pan, G., O'Rourke, K., and Dixit, V.M. (1998a). Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J. Biol. Chem. 273, 5841-5845.
38. Pan, H., Yin, C., Dyson, N.J., Harlow, E., Yamasaki, L., and Van Dyke, T. (1998b). Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Mol. Cell 2, 283-292.
39. Phillips, A.C., Bates, S., Ryan, K.M., Helin, K., and Vousden, K.H. (1997). Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev. 11, 1853-1863.
40. Pierce, A.M., Gimenez-Conti, I.B., Schneider-Broussard, R., Martinez, L.A., Conti, C.J., and Johnson, D.G. (1998). Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc. Natl. Acad. Sci. USA 95, 8858-8863.
41. Roulston, A., Reinhard, C., Amiri, P., and Williams, L.T. (1998). Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J. Biol. Chem. 273, 10232-10239.
42. Rowan, S., Ludwig, R.L., Haupt, Y., Bates, S., Lu, X., Oren, M., and Vousden, K.H. (1996). Specific loss of apoptotic but not cell cycle arrest funtion in a human tumour derived p53 mutant. EMBO J. 15, 827-838.
43. Ruben, S.M., Dillon, P.J., Shreck, R., Henkel, T., Chen, C.-H., Maher, M., Baeuerle, P.A., and Rosen, C.A. (1991). Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-κB. Science 251, 1490-1493.
44. Sanna, M.G., Duckett, C.S., Richter, B.W. M., Thompson, C.B., and Ulevitch, R.J. (1998). Selective activation of JNK1 is necessary for the antiapoptotic activity of hILP. Proc. Natl. Acad. Sci. USA 95, 6015-6020.
45. Shao, R., Karunagaran, D., Zhou, B.P., Li, K., Lo, S.S., Deng, J., Chiao, P., and Hung, M.C. (1997). Inhibition of nuclear factor-κB activity is involved in E1A-mediated sensitization of radiation-induced apoptosis. J. Biol. Chem. 272, 32739-32742.
46. Tewari, M., and Dixit, V.M. (1995). Fas-and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 270, 3255-3260.
47. Thome, M., Schneider, P., Hofmann, K., Fickenscher, H., Meinl, E., Neipel, F., Mattmann, C., Burns, K., Bodmer, J.L., Schroter, M., et al. (1997). Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386, 517-521.
48. Tsai, K.Y., Hu, Y., Macleod, K.F., Crowley, D., Yamasaki, L., and Jacks, T. (1998). Mutation of E2F-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol. Cell 2, 293-304.
49. Van Antwerp, D.J., Martin, S.J., Kafri, T., Green, D.R., and Verma, I.M. (1996). Suppression of TNFα induced apoptosis by NF-κB. Science 274, 787-790.
50. Vojtesek, B., Bartek, J., Midgley, C.A., and Lane, D.P. (1992). An immunochemical analysis of the human nuclear phosphoprotein p53. J. Immunol. Methods 151, 237-244.
51. Wang, C., Mayo, M.W., and Baldwin, A.S., Jr. (1996). TNF-and cancer therapy induced apoptosis: potentiation by inhibition of NF-κB. Science 274, 784-787.
52. Wang, C.Y., Mayo, M.W., Korneluk, R.G., Goeddel, D.V., and Baldwin, A.S. (1998). NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and C-IAP1 and C-IAP2 to suppress caspase 8 activation. Science 281, 1680-1683.
53. Whiteside, S.T., Epinat, J.-C., Rice, N., and Israel, A. (1997). IκB∈, a novel member of the IκB family, controls RelA and cRel NF-κB activity. EMBO J. 16, 1413-1426.
54. Yen, W.C., Shahian, A., Speiser, D., Kraunus, J., Billia, F., Wakeham, A., De la Pompa, J.L., Ferrick, D., Hum, B., Iscove, N., et al. (1997). Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7, 715-725.
55. Zandi, E., and Karin, M. (1999). Bridging the gap: composition, regulation and physiological function of the kB kinase complex. Mol. Cell. Biol. 19, 4547-4551.
56. Zhou, Q., Snipas, S., Orth, K., Muzio, M., Dixit, V.M., and Salvesen, G.S. (1997). Target protease specificity of the viral serpin CrmA. Analysis of five caspases. J. Biol. Chem. 272, 7797-7800.
57. Zhou, Q., Krebs, J.F., Snipas, S.J., Price, A., Alnemri, E.S., Tomaselli, K.J., and Salvesen, G.S. (1998). Interaction of the baculovirus anti-apoptotic protein p35 with caspases. Specificity, kinetics, and characterization of the caspase/p35 complex. Biochemistry 37, 10757-10765.
58. Zhu, L., Vandenheuvel, S., Helin, K., Fattaey, A., Ewen, M., Livingston, D., Dyson, N., and Harlow, E. (1993). Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7, 1111-1125.
59. Zou, H., Henzel, W.J., Liu, X., Lutschg, A., and Wand, X. (1997). Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase 3. Cell 90, 405-413.